PBH logo

PRESTIGE CONSUMER HEALTHCARE

PBHNYSE
๐Ÿ† #1918 by market capEarnings Nov 5US Equity
$46.74โ–ผ $0.19 (โˆ’0.40%)
๐ŸŒ™ After hours$46.74โ–ฒ 0.00%Regular close ยท extended-hours price shown
๐Ÿ””
Track PBH
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ผ 0.4%
7dโ–ฒ 1.7%
14dโ–ผ 0.4%
30dโ–ผ 9.8%
ytdโ–ผ 24.2%
1yโ–ผ 25.2%
๐ŸฆMarket Cap
$2.21B
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
-4.3%
Declining
๐Ÿ“ŠGross Margin
53.3%
Healthy
๐Ÿ’ตFCF Margin
21.3%
Strong
โš–๏ธP/S Ratio
2.0x
Cheap
Otter Score
76
Good

Trading Snapshot

Day Range
$46.27 โ€“ $47.61
52-Week Range
$42.62 โ€“ $71.07
Volume
$3.22B
Avg Volume
$3.72B
Shares Outstanding
47.4M
Next Earnings
Nov 4, 2026

Fundamentals Snapshot

Annual Revenue
$1.09B
Last Q Revenue
$266M
P/E Ratio
13.0
P/S Ratio
2.0x
EPS (TTM)
$3.62
Dividend Yield
0.00%
Dilution (1yr)
โˆ’1.0%

Why Investors Own PBH

  • โœ“High-growth profile โ€” revenue up +31.9% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 63% gross margin and 24% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

PBH logo

PRESTIGE CONSUMER HEALTHCARE

PBH
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$1.1Bโ–ผ โˆ’4.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
52.8%โ–ผ โˆ’5.3% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnโ€™t profitable yet.
$309Mโ–ผ โˆ’8.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$246Mโ–ฒ +1.3% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerโ€™s slice.
47.6Mโ–ผ โˆ’1.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
โˆ’$2.0Bโ–ผ โˆ’$958M YoY
StockOtter ยท stockotter.space

About PRESTIGE CONSUMER HEALTHCARE

Prestige Consumer Healthcare Inc., along with its various divisions, is involved in the creation, production, promotion, and distribution of non-prescription health and personal care items across both domestic (U.S.) and global markets. The company's business activities are structured into two principal areas: North American Over-the-Counter Healthcare and International Over-the-Counter Healthcare. Their extensive brand catalog features a diverse array of consumer health solutions, including popular choices for pain relief (such as BC/Goody's), infant care (Boudreaux's Butt Paste), sore throat remedies (Chloraseptic), vision care (Clear Eyes, TheraTears), wart treatment (Compound W), dental hygiene (DenTek), earwax removal (Debrox), and motion sickness prevention (Dramamine). The product line further extends to include digestive aids (Fleet, Gaviscon), cough suppressants (Luden's), feminine hygiene items (Monistat, Summer's Eve), treatments for lice and parasites (Nix), nasal washes (Fess), and rehydration therapies (Hydralyte). These offerings reach consumers through a wide range of retail channels, such as large discount retailers, pharmacies, supermarkets, dollar stores, convenience outlets, membership-based clubs, and digital commerce platforms. Founded in 1996 and based in Tarrytown, New York, the organization operated under the name Prestige Brands Holdings, Inc. until its rebranding to Prestige Consumer Healthcare Inc. in August 2018.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿ’งDilutionโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Good
76/100

Analyst Price Target

โ“˜
Average Target
$52.19
โ–ฒ +11.7% Upside
High Target$60.39
Low Target$48.30
Based on 26 analysts

Latest News & Updates

Defense Worldยท4d ago

Premium Brands (TSE:PBH) Reaches New 52-Week Low โ€“ Hereโ€™s What Happened

Premium Brands Holdings Co. (TSE: PBH - Get Free Report) hit a new 52-week low during trading on Wednesday. The company traded as low as C$75.25 and last traded at C$75.55, with a volume of 13629 shares changing hands. T

Zacks Investment Researchยท15d ago

PBH or NEOG: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Neogen (NEOG). But which of these two stocks is more attractive to value investors?

Seeking Alphaยท19d ago

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript

GlobeNewsWireยท21d ago

Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference

TARRYTOWN, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Ron Lombardi, Chairman, President, & CEO and Christine Sacco, CFO and COO will participate in a firesi

PRNewsWireยท28d ago

Football Stress May Be Following Fans to Bed, According to the Inaugural DenTekยฎ Football Stress Test

National survey commissioned by DenTek, the #1 OTC dental guard brand for nighttime teeth grinding, finds nearly 8 in 10 football fans keep thinking about the game after it ends, with many reporting stress-related behavi

Zacks Investment ResearchยทAug 28

PBH vs. SYK: Which Stock Is the Better Value Option?

Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now